×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 8: Closing Plenary - Data and Technology Strategy
Session Chair(s)
Pritibha Singh, MBA, MSc
Senior Manager, Corporate Affairs Analytics & Insights
Novartis AG, Switzerland
Advances in data science, artificial intelligence (AI) and machine learning (ML) are transforming the healthcare, pharmaceutical, and regulatory industries. In this session we will discuss the regulatory developments, challenges, opportunities and future perspectives on data science, AI and ML.
Learning Objective : At the conclusion of this session, participants should be able to:- Discuss regulatory developments in data science, AI and ML
- Identify regulatory challenges and opportunities with data science, AI and ML
- Illustrate the future regulatory perspectives on data science, AI and ML
Speaker(s)
Speaker
Ram Iyer, MS
FDA, United States
Chief Data Officer